Neoajuvant Tislelizumab Combined with Chemotherapy for Initially Unresectable Stage IIIA/N2 Non-small Cell Lung Cancer
Clinical trial NCT06614231 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06614231
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-20
- Primary completion
- 2028-09-08
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.